68 institutions reported holding $25.7M of NERVGEN PHARMA CORP (NGEN) in SEC 13F filings for 2026-06-30. Largest institutional holders: Empery Asset Management, LP ($8.2M), Rock Springs Capital Management LP ($2.5M), DAFNA Capital Management LLC ($2.2M), Ghisallo Capital Management LLC ($2.1M), ARMISTICE CAPITAL, LLC ($1.4M). Source: SEC Form 13F.
Source: SEC Form 13F filings · as of 2026-06-30